OSF Cancer institute joins National Research Network, expanding clinical trial opportunities WEEK | 25 News Now
Cancer Foundation Awards $95,000 to Local Pediatric Cancer Programs The Santa Barbara Independent
A multi-institutional research team led by Georgia State University Regents' Professor Emerita of Biochemistry and Biophysical Chemistry Jenny J. Yang has developed a new class of protein-based MRI contrast agents that detect invasive lung cancer and metastatic disease at earlier stages than conventional imaging…
Most patients with localized appendix cancer may be able to safely avoid chemotherapy after surgery, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.
New Tools Predict Which Tumors Will Respond to Treatment by Comparing Their Internal “Floor Plans” | Newswise newswise.com
When Standard Pancreatic Cancer Treatments Weren’t Enough City of Hope
Arizona's clinical trials help accelerate cancer treatment breakthroughs 12News
Иммунитет против рака можно включить одной молекулой? Учёные проверяют сенсационную идею Правда.Ру
Most Patients with Appendix Cancer May Avoid Chemotherapy After Surgery, Study Suggests | Newswise newswise.com
Measuring the Human Side of Cancer Research | Newswise newswise.com
The FDA has granted accelerated approval to sevabertinib as first-line treatment for adults with locally advanced or metastatic non-squamous non-small cell lung cancer. The approval of sevabertinib (Hyrnuo, Bayer Healthcare Pharmaceuticals), which expands upon the agent’s existing indication for patients who received…
Placebos in Cancer Clinical Trials: What Patients Need to Know Cure Today
Prostate Cancer: Exercise Program Reduces Treatment Side Effects healthline.com
